58 related articles for article (PubMed ID: 17983597)
1. The polyglutamine-expanded protein ataxin-3 decreases bcl-2 mRNA stability.
Tien CL; Wen FC; Hsieh M
Biochem Biophys Res Commun; 2008 Jan; 365(2):232-8. PubMed ID: 17983597
[TBL] [Abstract][Full Text] [Related]
2. Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease.
Yu YC; Kuo CL; Cheng WL; Liu CS; Hsieh M
J Neurosci Res; 2009 Jun; 87(8):1884-91. PubMed ID: 19185026
[TBL] [Abstract][Full Text] [Related]
3. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
Tsai HF; Tsai HJ; Hsieh M
Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
[TBL] [Abstract][Full Text] [Related]
4. Decreased protein synthesis of Hsp27 associated with cellular toxicity in a cell model of Machado-Joseph disease.
Chang WH; Tien CL; Chen TJ; Nukina N; Hsieh M
Neurosci Lett; 2009 Apr; 454(2):152-6. PubMed ID: 19429074
[TBL] [Abstract][Full Text] [Related]
5. Dynamic expression of Hsp27 in the presence of mutant ataxin-3.
Chang WH; Cemal CK; Hsu YH; Kuo CL; Nukina N; Chang MH; Hu HT; Li C; Hsieh M
Biochem Biophys Res Commun; 2005 Oct; 336(1):258-67. PubMed ID: 16126176
[TBL] [Abstract][Full Text] [Related]
6. Expression of expanded polyglutamine protein induces behavioral changes in Drosophila (polyglutamine-induced changes in Drosophila).
Kim YT; Shin SM; Lee WY; Kim GM; Jin DK
Cell Mol Neurobiol; 2004 Feb; 24(1):109-22. PubMed ID: 15049515
[TBL] [Abstract][Full Text] [Related]
7. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
[TBL] [Abstract][Full Text] [Related]
8. p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons.
Chou AH; Lin AC; Hong KY; Hu SH; Chen YL; Chen JY; Wang HL
Neurochem Int; 2011 Feb; 58(2):145-52. PubMed ID: 21092747
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL.
Chou AH; Yeh TH; Kuo YL; Kao YC; Jou MJ; Hsu CY; Tsai SR; Kakizuka A; Wang HL
Neurobiol Dis; 2006 Feb; 21(2):333-45. PubMed ID: 16112867
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.
Chai Y; Koppenhafer SL; Bonini NM; Paulson HL
J Neurosci; 1999 Dec; 19(23):10338-47. PubMed ID: 10575031
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms to control degradation of polyglutamine-containing protein].
Nakayama K
Rinsho Shinkeigaku; 2003 Nov; 43(11):906-8. PubMed ID: 15152500
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons.
Wang HL; Chou AH; Lin AC; Chen SY; Weng YH; Yeh TH
Exp Neurol; 2010 Aug; 224(2):486-94. PubMed ID: 20546728
[TBL] [Abstract][Full Text] [Related]
13. A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.
Colomer Gould VF; Goti D; Pearce D; Gonzalez GA; Gao H; Bermudez de Leon M; Jenkins NA; Copeland NG; Ross CA; Brown DR
Neurobiol Dis; 2007 Sep; 27(3):362-9. PubMed ID: 17632007
[TBL] [Abstract][Full Text] [Related]
14. Polyglutamine-expanded ataxin-7 activates mitochondrial apoptotic pathway of cerebellar neurons by upregulating Bax and downregulating Bcl-x(L).
Wang HL; Yeh TH; Chou AH; Kuo YL; Luo LJ; He CY; Huang PC; Li AH
Cell Signal; 2006 Apr; 18(4):541-52. PubMed ID: 15964171
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
[TBL] [Abstract][Full Text] [Related]
16. Potassium channel dysfunction and depolarized resting membrane potential in a cell model of SCA3.
Jeub M; Herbst M; Spauschus A; Fleischer H; Klockgether T; Wuellner U; Evert BO
Exp Neurol; 2006 Sep; 201(1):182-92. PubMed ID: 16765348
[TBL] [Abstract][Full Text] [Related]
17. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
18. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
[TBL] [Abstract][Full Text] [Related]
19. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta -fibrils.
Bevivino AE; Loll PJ
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11955-60. PubMed ID: 11572942
[TBL] [Abstract][Full Text] [Related]
20. p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome.
Wang H; Jia N; Fei E; Wang Z; Liu C; Zhang T; Fan J; Wu M; Chen L; Nukina N; Zhou J; Wang G
J Neurochem; 2007 Jun; 101(6):1651-61. PubMed ID: 17302910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]